These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29746819)

  • 1. Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.
    Prior SM; Mann KG; Freeman K; Butenas S
    Anal Biochem; 2018 Jun; 551():19-25. PubMed ID: 29746819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
    Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
    Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T; Sugiyama N; Morishima Y; Shibano T
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interconnectedness of global hemostasis assay parameters in simultaneously evaluated thrombin generation, fibrin generation and clot lysis in normal plasma.
    Xin KZ; Chang WC; Ovanesov MV
    Thromb Res; 2016 Apr; 140():132-139. PubMed ID: 26632515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring thrombin generation as a tool for predicting hemostatic potential and transfusion requirements following trauma.
    Cardenas JC; Rahbar E; Pommerening MJ; Baer LA; Matijevic N; Cotton BA; Holcomb JB; Wade CE
    J Trauma Acute Care Surg; 2014 Dec; 77(6):839-45. PubMed ID: 25099452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin Generation Assays (TGAs).
    Salvagno GL; Berntorp E
    Methods Mol Biol; 2017; 1646():515-522. PubMed ID: 28804851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of platelet-derived and plasma factor VIII efficacy using a novel native whole blood thrombin generation assay.
    Baumgartner CK; Zhang G; Kuether EL; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2015 Dec; 13(12):2210-9. PubMed ID: 26453193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel assay for studying the involvement of blood cells in whole blood thrombin generation.
    Wan J; Konings J; Yan Q; Kelchtermans H; Kremers R; de Laat B; Roest M
    J Thromb Haemost; 2020 Jun; 18(6):1291-1301. PubMed ID: 32108990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay.
    Wan J; Roberts LN; Hendrix W; Konings J; Ow TW; Rabinowich L; Barbouti O; de Laat B; Arya R; Patel VC; Roest M; Lisman T; Bernal W
    J Thromb Haemost; 2020 Apr; 18(4):834-843. PubMed ID: 31997515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the impact of instrument variation and automated software algorithms on the TGT in hemophilia and normalized plasma.
    Woodle SA; Shibeko AM; Lee TK; Ovanesov MV
    Thromb Res; 2013 Sep; 132(3):374-80. PubMed ID: 23953593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation.
    Wan J; Tanratana P; Roest M; Gruber A; Pawlinski R; Wolberg AS; Mackman N; Grover SP
    Blood Adv; 2023 May; 7(9):1915-1925. PubMed ID: 36583671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical enhancement of the intrinsic pathway-induced thrombin generation in human plasma by melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, or heparin.
    Furugohri T; Morishima Y
    Thromb Res; 2015 Sep; 136(3):658-62. PubMed ID: 26188924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
    Wegert W; Harder S; Bassus S; Kirchmaier CM
    Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples.
    Rice NT; Szlam F; Varner JD; Bernstein PS; Szlam AD; Tanaka KA
    PLoS One; 2016; 11(5):e0154127. PubMed ID: 27196067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serendipitously identified novel small molecule procoagulant compound giving rise to a high-throughput screening assay based on human plasma.
    Gustafsson D; Nielsen S; McPheat J; Wågberg F; Kaspersson K; Rohman M; Ulander J; Fex T; Fjellström O; Deinum J
    Thromb Res; 2013 Aug; 132(2):248-55. PubMed ID: 23830061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis.
    Zanetto A; Campello E; Bulato C; Willems R; Konings J; Roest M; Gavasso S; Nuozzi G; Toffanin S; Zanaga P; Burra P; Russo FP; Senzolo M; de Laat B; Simioni P
    J Thromb Haemost; 2024 Feb; 22(2):480-492. PubMed ID: 37866518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Determinants of Thrombin Generation Measured in Presence and Absence of Platelets-Results from the Gutenberg Health Study.
    Panova-Noeva M; Schulz A; Spronk HM; Beicht A; Laubert-Reh D; van Oerle R; Arnold N; Prochaska JH; Blettner M; Beutel M; Pfeiffer N; Münzel T; Lackner KJ; Ten Cate H; Wild PS
    Thromb Haemost; 2018 May; 118(5):873-882. PubMed ID: 29614519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
    Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
    Sørensen B; Persson E; Ingerslev J
    Br J Haematol; 2007 Apr; 137(2):158-65. PubMed ID: 17391496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.